Caspase inhibition in apoptotic T cells triggers necrotic cell death depending on the cell type and the proapoptotic stimulus

Journal of Cellular Biochemistry

Volumn 97, Issue 6, 2006, Pages 1350-1361

  Scheller, Carsten ^a   Knöferle, Johanna ^a   Ullrich, Anett ^a   Prottengeier, Johannes ^a   Racek, Tomas ^a   Sopper, Sieghart ^b   Jassoy, Christian ^c   Rethwilm, Axel ^a   Koutsilieri, Eleni ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

A3.01; Apoptosis; Caspase inhibition; CD95; Necrosis; T cells; ZVAD

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BUTYLATED HYDROXYANISOLE; CAMPTOTHECIN; CASPASE; CASPASE INHIBITOR; DNA FRAGMENT; DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; ENZYME INHIBITOR; ETOPOSIDE; FAS ANTIBODY; FAS ANTIGEN; KETONE DERIVATIVE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 7C11; NALPHA TOSYLPHENYLCHLOROMETHYLKETONE; SCAVENGER; SERPASE INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE; CELL PROTECTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

AMINO ACID CHLOROMETHYL KETONES; ANTIGENS, CD95; APOPTOSIS; CASPASES; CELL DEATH; CELL LINE; CYSTEINE PROTEINASE INHIBITORS; HUMANS; NECROSIS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TIME FACTORS;

EID: 33645653111     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20670     Document Type: Article

References (47)

1. Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH. 1993. Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178:2231-2235.
2. Ashany D, Savir A, Bhardwaj N, Elkon KB. 1999. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway. J Immunol 163:5303-5311.
3. Aubert M, Jerome KR. 2003. Apoptosis prevention as a mechanism of immune evasion. Int Rev Immunol 22:361-371.
4. Boise LH, Thompson CB. 1997. Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc Natl Acad Sci USA 94:3759-3764.
5. Essmann F, Bantel H, Totzke G, Engels IH, Sinha B, Schulze-Osthoff K, Janicke RU. 2003. Staphylococcus aureus alpha-toxin-induced cell death: Predominant necrosis despite apoptotic caspase activation. Cell Death Differ 10:1260-1272.
6. Fiers W, Beyaert R, Declercq W, Vandenabeele P. 1999. More than one way to die: Apoptosis, necrosis and reactive oxygen damage. Oncogene 18:7719-7730.
7. Folks T, Benn S, Rabson A, Theodore T, Hoggan MD, Martin M, Lightfoote M, Sell K. 1985. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)- associated retrovirus. Proc Natl Acad Sci USA 82:4539-4543.
8. Hetz CA, Hunn M, Rojas P, Torres V, Leyton L, Quest AF. 2002. Caspase-dependent initiation of apoptosis and necrosis by the Fas receptor in lymphoid cells: Onset of necrosis is associated with delayed ceramide increase. J Cell Sci 115:4671-4683.
9. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J. 2000. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 1:489-495.
10. Joly LM, Mucignat V, Mariani J, Plotkine M, Charriaut-Marlangue C. 2004. Caspase inhibition after neonatal ischemia in the rat brain. J Cereb Blood Flow Metab 24:124-131.
11. Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M, Kennedy N, Kovacsovics M, Tschopp J. 2000. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 10:640-648.
12. Kemp TJ, Kim JS, Grist SA, Griffith TS. 2003. Induction of necrotic tumor cell death by TRAIL/Apo-2L. Apoptosis 8:587-599.
13. Kim SO, Han J. 2001. Pan-caspase inhibitor zVAD enhances cell death in RAW246.7 macrophages. J Endotoxin Res 7:292-296.
14. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME. 1995. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14:5579-5588.
15. Lin Y, Devin A, Rodriguez Y, Liu ZG. 1999. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 13:2514-2526.
16. Loetscher H, Niederhauser O, Kemp J, Gill R. 2001. Is caspase-3 inhibition a valid therapeutic strategy in cerebral ischemia? Drug Discov Today 6:671-680.
17. Los M, Mozoluk M, Ferrari D, Stepczynska A, Stroh C, Renz A, Herceg Z, Wang ZQ, Schulze-Osthoff K. 2002. Activation and caspase-mediated inhibition of PARP: A molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell 13:978-988.
18. Luschen S, Ussat S, Scherer G, Kabelitz D, Adam-Klages S. 2000. Sensitization to death receptor cytotoxicity by inhibition of fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression. J Biol Chem 275:24670-24678.
19. Majno G, Joris I. 1995. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146:3-15.
20. Martin DA, Siegel RM, Zheng L, Lenardo MJ. 1998. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal. J Biol Chem 273:4345-4349.
21. McCafferty-Grad J, Bahlis NJ, Krett N, Aguilar TM, Reis I, Lee KP, Boise LH. 2003. Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells. Mol Cancer Ther 2:1155-1164.
22. McGahon AJ, Costa Pereira AP, Daly L, Cotter TG. 1998. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system. Br J Haematol 101:539-547.
23. Micheau O, Solary E, Hammann A, Dimanche-Boitrel MT. 1999. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J Biol Chem 274:7987-7992.
24. Nagata S, Golstein P. 1995. The Fas death factor. Science 267:1449-1456.
25. O'Brien T, Lee D. 2004. Prospects for caspase inhibitors. Mini Rev Med Chem 4:153-165.
26. Okada M, Adachi S, Imai T, Watanabe K, Toyokuni SY, Ueno M, Zervos AS, Kroemer G, Nakahata T. 2004. A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: Caspase-Independent, necrosis-like programmed cell death mediated by serine protease activity. Blood 103:2299-2307.
27. Prabhakaran K, Li L, Borowitz JL, Isom GE. 2004. Caspase inhibition switches the mode of cell death induced by cyanide by enhancing reactive oxygen species generation and PARP-1 activation. Toxicol Appl Pharmacol 195:194-202.
28. Rescigno M, Piguet V, Valzasina B, Lens S, Zubler R, French L, Kindler V, Tschopp J, Ricciardi-Castagnoli P. 2000. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: A new role for Fas ligand in inflammatory responses. J Exp Med 192:1661-1668.
29. Robertson GS, Crocker SJ, Nicholson DW, Schulz JB. 2000. Neuroprotection by the inhibition of apoptosis. Brain Pathol 10:283-292.
30. Sayers TJ, Brooks AD, Seki N, Smyth MJ, Yagita H, Blazar BR, Malyguine AM. 2000. T cell lysis of murine renal cancer: Multiple signaling pathways for cell death via Fas. J Leukoc Biol 68:81-86.
31. Scheller C, Sopper S, Ehrhardt C, Flory E, Chen P, Koutsilieri E, Ludwig S, ter Meulen V, Jassoy C. 2002. Caspase inhibitors induce a switch from apoptotic to proinflammatory signaling in CD95-stimulated T lymphocytes. Eur J Immunol 32:2471-2480.
32. Smith KG, Strasser A, Vaux DL. 1996. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J 15:5167-5176.
33. Stroh C, Schulze-Osthoff K. 1998. Death by a thousand cuts: An ever increasing list of caspase substrates. Cell Death Differ 5:997-1000.
34. Tomaselli KJ. 2001. Modulation of apoptosis as a thera peutic strategy. Sci World J 1:104.
35. Tschopp J, Irmler M, Thome M. 1998. Inhibition of fas death signals by FLIPs. Curr Opin Immunol 10:552-558.
36. Vercammen D, Beyaert R, Denecker G, Goossens V, Van Loo G, Declercq W, Grooten J, Fiers W, Vandenabeele P. 1998a. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 187:1477-1485.
37. Vercammen D, Brouckaert G, Denecker G, Van de Craen M, Declercq W, Fiers W, Vandenabeele P. 1998b. Dual signaling of the Fas receptor: Initiation of both apoptotic and necrotic cell death pathways. J Exp Med 188:919-930.
38. Verhoven B, Krahling S, Schlegel RA, Williamson P. 1999. Regulation of phosphatidylserine exposure and phagocytosis of apoptotic T lymphocytes. Cell Death Differ 6:262-270.
39. Volbracht C, Leist M, Kolb SA, Nicotera P. 2001. Apoptosis in caspase-inhibited neurons. Mol Med 7:36-48.
40. Walsh CM, Wen BG, Chinnaiyan AM, O'Rourke K, Dixit VM, Hedrick SM. 1998. A role for FADD in T cell activation and development. Immunity 8:439-449.
41. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317.
42. Weiss A, Wiskocil RL, Stobo JD. 1984. The role of T3 surface molecules in the activation of human T cells: A two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J Immunol 133:123-128.
43. Wesselborg S, Engels IH, Rossmann E, Los M, Schulze-Osthoff K. 1999. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Blood 93:3053-3063.
44. Wilson CA, Browning JL. 2002. Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis. Cell Death Differ 9:1321-1333.
45. Wilson DJ, Alessandrini A, Budd RC. 1999. MEK1 activation rescues Jurkat T cells from Fas-induced apoptosis. Cell Immunol 194:67-77.
46. Yang YW, Wu CA, Morrow WJ. 2004. The apoptotic and necrotic effects of tomatine adjuvant. Vaccine 22:2316-2327.
47. Zhu H, Fearnhead HO, Cohen GM. 1995. An ICE-like protease is a common mediator of apoptosis induced by diverse stimuli in human monocytic THP.1 cells. FEBS Lett 374:303-308.